Merz Therapeutics Submits Application to the European Medicines Agency for New Indication of XEOMIN® in Pediatric Spasticity

Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that it has completed the ...
Reuters

Ipsen announces FDA approval of dysport for the treatment of lower limb spasticity in children

As Microsoft CEOs past and present gathered here to celebrate the company's 50th birthday, one leader said he is targeting a particular metric's improvement to guide his strategy on artificial ...
Business Wire

Revance to Present Data from Phase 2 JUNIPER Clinical Trial Evaluating DAXXIFY™ (DaxibotulinumtoxinA-lanm) Injection for the Treatment of Upper Limb Spasticity at the ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced an ...
Science Daily

Advanced universal control system may revolutionize lower limb exoskeleton control and optimize user experience

A team of researchers has developed a new method for controlling lower limb exoskeletons using deep reinforcement learning. The method enables more robust and natural walking control for users of ...
Pharmabiz

Allergan's Botox receives US FDA approval to treat pediatric patients with upper limb spasticity

Allergan plc, a global pharmaceutical leader, announced that the US Food and Drug Administration (FDA) approved the company's supplemental biologics application (sBLA) for Botox for the treatment of ...